15 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
facilities and products except for those deemed to be “mission critical.” On March 18, 2020, the FDA announced its intention to temporarily postpone … , while foreign inspections remained limited to those deemed “mission critical.” In March 2021, the U.S. Government Accountability Office issued
424B4
AMYT
Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
capabilities.
Our Strategy
Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing … and acquiring novel rare disease products. To achieve this mission, we are pursuing the following strategies:
Drive revenue growth for our existing commercial
F-1/A
2fpc9n
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
warc mjcygs3kw
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
3cj8xqgei838xtor2xlp
18 Dec 20
Draft registration statement
12:00am
424B4
2vc7mpca6gvgmu
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
k62b9
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.12.5
kgty7bsypsot fne9tow
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
jmb7xedl
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
ll1j1
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
8ame fd0aync
11 May 20
Draft registration statement (amended)
12:00am
DRS
8w8fabnk8s 5i52
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next